Studies

  1. Etrolizumab for maintenance of remission in UC

  2. Vedolizumab in paediatric IBD

  3. Etrolizumab vs adalimumab in UC

  4. Etrolizumab for induction & maintenance of remission in UC

  5. Risankizumab maintenance of remission in CD

  6. Vedolizumab in perianal CD

  7. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) in UC induction and maintenance